BUY Concord Biotech Limited — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: 1 year21 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Concord Biotech bonus issue sparks rally! Pharma stock jumps 6% on maiden share reward - Top things to know
NewsLivemint·21 Sept · yesterday
Bonus Alert: Stock with significant Jhunjhunwala family stake set to reward shareholders
NewsCnbc-Tv18·21 Sept · yesterday
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·21 Sept · yesterday
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·22 Sept · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.